Delivery Order SPE2DB22D1106-SPE2DB25FFJG9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections valued at $1,797.27. This contract is a firm fixed price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vehicle running through December 2026. The delivery order carries an ultimate completion date of September 5, 2025, and does not...
- The Defense Logistics Agency awarded a $14,862.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections with an ultimate completion date of August 4, 2025. This non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $15,411.44 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pen injections on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order utilizes no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $39,858.23 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $26,993.06 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $25,630.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This non-set-aside competitive award is scheduled for completion by August 4, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a $14,455.29 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $8,205.66 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections (0.5 mL). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 25, 2025, and performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,573.99 for Zepbound 10 mg/0.5 mL pen injections on May 30, 2025, with completion targeted for June 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFJG9Delivery Order
The Defense Logistics Agency awarded a $9,980.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injections. The contract, which is not set-aside, specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026, which serves as a critical procurement mechanism for military healthcare systems and other federal agencies. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal contract awards primarily with the Defense Logistics Agency and its Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products across multiple therapeutic domains to support defense and veteran healthcare systems. This particular delivery order for Zepbound, a diabetes medication, exemplifies the company's role in fulfilling specialized pharmaceutical needs for federal medical procurement, consistent with its demonstrated capability to meet competitive federal requirements through firm fixed-price contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 9/16/25 |